Post by VVMF

𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 - 𝗶𝗻 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮 As Australia’s only commercial-scale CDMO dedicated exclusively to viral vector development and manufacturing, VVMF - Viral Vector Manufacturing Facility plays a pivotal role in bringing cell and gene therapies from concept to clinic. Producing 𝗟𝗩 and 𝗔𝗔𝗩 vectors at clinical and commercial scale, VVMF provides deep technical and medical expertise to support innovators at every stage. With world-class expertise and end-to-end capability, our team includes Prof. Leszek Lisowski, PhD, MBA, Chief Technology Officer and Vectrologist, and Prof. Ian Alexander, Chief Medical Officer and Gene Therapy Clinician. Our capabilities include: 🔹 Vector R&D 🔹 Construct design and optimisation 🔹 Advanced process development 🔹 Clinical compliant manufacturing 5L to 500L 🔹 Technology transfer 🔹 Analytics to exacting quality standards. Looking to leverage Australia’s thriving biotech ecosystem? 👉 Ask Anita van der Meer about our wrap-around services and strategic advice. 📍 Connect with Anita at Advanced Therapies Week, San Diego 📅 February 9-12 📧 [email protected] #VVMF #UnlockingtheFutureofMedicine #AustralianAdvantage #AdvancedTherapies #CellandGeneTherapy #viralvectors

Video Content